Syros Reports First Quarter 2023 Financial Results and Provides a Corporate Update

Author's Avatar
May 10, 2023

Syros Pharmaceuticals (NASDAQ:SYRS), a biopharmaceutical company committed to advancing new standards of care for the frontline treatment of hematologic malignancies, today reported financial results for the quarter ended March 31, 2023 and provided a corporate update.